News | December 17, 2010

First Detachable Hydrogel Embolic Device Now Available


December 17, 2010 – The first truly detachable hydrogel polymer embolic device is now available nationwide. The AZUR Peripheral HydroCoil 35 platinum coil embolization system, from Terumo Interventional Systems, is designed for treating high-flow and challenging blood vessels, vascular malformations and aneurysms.

The 0.035-inch coils provide greater filling capacity, packing density and mechanical occlusion.

The hydrogel coating undergoes limited expansion within the first three minutes, and fully expands within 20 minutes, offering nearly four times more filling volume than a platinum coil of the same size. It deploys rapidly - taking less than a second - while offering physicians the flexibility to position and observe the behavior of the coil in the vasculature prior to detachment. It can also be retracted and repositioned until it is securely placed, reducing the risk of non-target embolization and coil migration.

In addition, the system is the only hydrogel embolic indicated for peripheral applications that is detachable and compatible with 0.038-inch lumen catheters. The microporous expandable hydrogel is biologically inert and provides scaffolding for natural tissue proliferation.

"In our experience, the AZUR Detachable 35 is an excellent embolization system that is very capable of treating higher capacity lesions with fewer coils, while effectively minimizing risk of coil migration,” said Craig Greben, M.D., chief, division of vascular and interventional radiology, North Shore University Hospital, Manhasset, N.Y. “The larger coil size is highly deliverable and provides us with added confidence in treating high-blood flow areas or particularly challenging anatomies.”

The device is intended to reduce or block the rate of blood flow in vessels of the peripheral vasculature. It is designed for use in the interventional radiologic management of arteriovenous malformations, arteriovenous fistulae, aneurysms and other lesions of the peripheral vasculature.

For more information: www.terumois.com


Related Content

News | Embolization devices

July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

Home July 28, 2022
Home
News | Embolization devices
March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...
Home March 31, 2022
Home
News | Embolization devices

March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral ...

Home March 29, 2022
Home
News | Embolization devices

October 16, 2017 — Medtronic announced the launch of the Concerto 3-D Detachable Coil System at the Cardiovascular and ...

Home October 16, 2017
Home
News | Embolization devices

February 24, 2016 — ArtVentive Medical Group Inc. announced enrollment in the ongoing ArtVentive EOS Endoluminal ...

Home February 24, 2016
Home
Technology | Embolization devices

January 14, 2016 — Penumbra Inc. announced the U.S. launch of its new POD Packing Coil, designed as a complementary ...

Home January 14, 2016
Home
News | Embolization devices

December 17, 2015 — ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive ...

Home December 17, 2015
Home
Technology | Embolization devices

August 17, 2015 — Merit Medical Systems Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug ...

Home August 17, 2015
Home
Subscribe Now